查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2089117

預防性醫療保健技術和服務市場：2026-2032年全球市場預測（按服務、交付方式、技術類型、最終用戶和應用分類）

Preventive Healthcare Technologies & Services Market by Service, Delivery Mode, Technology Type, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，預防性醫療保健技術和服務市場將成長至 5,730 億美元，複合年成長率為 11.49%。

主要市場統計數據
基準年 2025 2674.7億美元
預計年份：2026年 2966.5億美元
預測年份 2032 5730億美元
複合年成長率 (%) 11.49%

介紹

預防性醫療保健技術和服務正從一次性篩檢計畫轉向數據驅動的持續性健康風險管理。這項需求源自於全球非傳染性疾病負擔的加重（根據世界衛生組織統計，非傳染性疾病約佔全球所有死亡人數的74%），以及人口老化加劇了對早期檢測、疫苗接種、藥物依從性和生活方式改善的需求。

預防醫學領域的變革性變化

消費者醫療保健設備、價值醫療、分散式診斷和人群健康分析的整合正在重新定義預防醫學領域。預防服務不再局限於年度體檢，而是擴大涵蓋持續生物特徵監測、居家檢測、遠端醫療分診、自動提醒、疫苗接種宣傳活動和個人化指導。

人工智慧（AI）的累積影響

人工智慧 (AI) 正在加速從被動治療轉向預測性預防的轉變。 AI 模型可輔助進行心血管疾病、糖尿病、癌症篩檢合格、藥物依從性、跌倒、虛弱以及可避免的急診就診的風險評分。電腦視覺已應用於放射學、皮膚病學、病理學和眼科學等領域的規範診斷流程中，在這些領域，早期檢測可以顯著改善患者的預後。

關鍵區域洞察

亞太地區是預防性醫療技術領域最具活力的地區之一。這主要得益於大規模的人口基數、慢性病盛行率的不斷上升，以及中國、印度、日本、韓國、新加坡和澳洲等國政府主導的數位健康舉措。隨著日本和韓國人口老化加劇，對防跌倒、遠端監測、失智症風險管理和早期檢測服務的需求日益成長。同時，印度和東南亞國家在數位身分、基層醫療、疫苗接種記錄和社區篩檢等方面的應用也日益普及。

關鍵群體特定見解

在東南亞國協，預防醫學正透過數位健康平台的應用、基層醫療的現代化、全民健保的擴大以及感染疾病監測方面的跨境合作而得到推進。新加坡以科技驅動的醫療模式常常成為區域標桿，而印尼、泰國、越南、馬來西亞和菲律賓則正透過行動醫療、免疫接種計畫、社區篩檢和數位公共衛生工具來擴大醫療服務的覆蓋範圍。

主要國家的概況

美國憑藉著保險公司的創新、雇主主導的健康計劃、高數位醫療普及率、規範的軟體部署流程以及在保險政策中廣泛採用預防性服務建議，在預防性健康技術領域持續保持領先地位。加拿大則透過其公共醫療保健系統、免疫接種、癌症篩檢和基層醫療改革，強調主導預防。同時，墨西哥和巴西正利用公營和私營基層醫療網路，應對糖尿病、肥胖、高血壓、心血管疾病以及婦幼保健等優先事項。

為行業領導者提供的實用建議

產業領導者應優先考慮經臨床檢驗的解決方案，這些方案需能實際降低風險、成本、減少漏診、延緩疾病進展或彌補醫療服務缺口。產品需要與電子健康記錄、保險公司工作流程、藥房系統、實驗室網路、連網型設備和公共衛生登記系統整合，從獨立的健康管理工具發展成為一體化的預防性醫療保健基礎設施。

調查方法

本執行摘要基於二手研究和分析研究方法，利用公開可用和經常被引用的來源，包括世界衛生組織 (WHO)、經濟合作暨發展組織(OECD)、世界銀行、國家衛生機構、監管機構、保險公司、數位健康法規和同行評審的資訊來源文獻的政策文件。

結論

預防性醫療保健技術和服務對於未來永續醫療保健系統至關重要。臨床證據、連網資料、人工智慧驅動的風險預測、安全互通性和便利服務交付的整合領域，蘊藏著巨大的發展機會。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 預防性醫療保健技術與服務市場：依服務分類

  • 基因檢測服務
    • 職業篩檢
    • 遺傳性癌症檢測
    • 藥理基因體學檢測
  • 生活方式管理
    • 健身指導
    • 營養諮詢
    • 壓力管理
  • 預測分析
    • 人工智慧驅動的預測模型
    • 風險評估工具
  • 預防性篩檢
    • 癌症篩檢
    • 心血管篩檢
    • 糖尿病篩檢
    • 骨質疏鬆症篩檢
  • 疫苗接種服務
    • 季節性疫苗接種
    • 旅行疫苗接種
    • 職場疫苗接種

第8章 預防性醫療保健技術與服務市場：依交付模式分類

  • 居家型
    • 家庭到府醫療服務
    • 自行管理型
  • 面對面
    • 診所
    • 醫院基地
    • 藥局
  • 行動診所
    • 公車診所
    • 臨時診所
  • 虛擬的
    • 基於應用程式
    • 遠端監控
    • 遠距醫療

第9章 預防性醫療保健技術與服務市場：依技術類型分類

  • 早期檢測與篩檢技術
  • 慢性病管理技術
  • 疫苗技術
  • 數位健康解決方案
  • 穿戴式科技

第10章 預防性醫療保健技術與服務市場：依最終使用者分類

  • 門診部
    • 診所
    • 診斷中心
  • 企業健康服務提供者
    • 現場專案
    • 虛擬項目
  • 居家醫療
    • 在家遠端監控
    • 自我管理
  • 醫院
    • 基層醫療機構
    • 專科醫院
  • 個人
    • 消費品
    • 自助服務應用程式

第11章 預防性醫療保健技術與服務市場：按應用領域分類

  • 預防心血管疾病
    • 膽固醇監測
    • 高血壓管理
    • 生活方式乾預
  • 糖尿病預防
    • 血糖值監測
    • 生活方式指導
  • 感染疾病預防
    • 疫苗接種
    • 預防性治療
  • 癌症篩檢
    • 乳癌篩檢
    • 大腸直腸癌篩檢
    • 肺癌篩檢

第12章 預防性醫療保健技術與服務市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章 預防性醫療保健技術與服務市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 預防性醫療保健技術與服務市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Abbott Laboratories
  • Accenture PLC
  • AliveCor Inc
  • Alphabet Inc
  • Apple Inc
  • CitiusTech Inc
  • Cognizant Technology Solutions Corporation
  • Dexcom Inc
  • Garmin Ltd
  • General Electric HealthCare Technologies Inc
  • GSK plc
  • Illumina Inc
  • Johnson & Johnson
  • Koninklijke Philips NV
  • McKesson Corporation
  • Medtronic plc
  • Merck & Co Inc
  • Moderna Inc
  • Myriad Genetics Inc
  • Pfizer Inc
  • Quest Diagnostics Incorporated
  • ResMed Inc
  • Roche Holding AG
  • Siemens Healthineers AG
  • Tata Consultancy Services Limited
  • Teladoc Health Inc
  • UnitedHealth Group Incorporated
  • Wipro Limited
Product Code: MRR-EC2E133E3316

The Preventive Healthcare Technologies & Services Market is projected to grow by USD 573.00 billion at a CAGR of 11.49% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 267.47 billion
Estimated Year [2026] USD 296.65 billion
Forecast Year [2032] USD 573.00 billion
CAGR (%) 11.49%

Introduction

Preventive healthcare technologies and services are moving from episodic screening programs to continuous, data-enabled health risk management. Demand is supported by the global burden of noncommunicable diseases, which the World Health Organization reports account for roughly 74% of all deaths worldwide, and by aging populations that increase the need for earlier detection, vaccination, medication adherence, and lifestyle intervention.

The sector is increasingly defined by connected diagnostics, wearable devices, remote patient monitoring, digital therapeutics, genomic screening, employer wellness platforms, immunization management, and risk-stratified primary care. Health systems, payers, employers, and public agencies are prioritizing prevention because it can reduce avoidable hospitalizations, improve quality-adjusted outcomes, and help manage rising healthcare expenditure documented across OECD and World Bank datasets.

Transformative Shifts in the Preventive Healthcare Landscape

The preventive healthcare landscape is being reshaped by the convergence of consumer health devices, value-based care, decentralized diagnostics, and population health analytics. Preventive services are no longer limited to annual visits; they increasingly include continuous biometric monitoring, home testing, telehealth triage, automated reminders, vaccination outreach, and personalized coaching.

Regulatory and reimbursement models are also evolving. In the United States, Medicare and commercial payers cover multiple preventive services without cost sharing under defined criteria, while the European Union is advancing digital health data interoperability through the European Health Data Space. Across Asia-Pacific, national digital health infrastructure programs are expanding access to vaccination records, screening pathways, chronic disease prevention, and digitally enabled primary care services.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is accelerating the shift from reactive care to predictive prevention. AI models support risk scoring for cardiovascular disease, diabetes, cancer screening eligibility, medication nonadherence, falls, frailty, and avoidable emergency utilization. Computer vision is already used in regulated diagnostic workflows, including radiology, dermatology, pathology, and ophthalmology, where early detection can materially change patient outcomes.

The cumulative impact is strongest when AI is combined with clinically governed data, evidence-based protocols, transparent model validation, and human oversight. Adoption remains constrained by bias, explainability, cybersecurity, data quality, and medical liability concerns, prompting regulators such as the U.S. FDA and the European Union to increase scrutiny of software as a medical device and high-risk AI systems.

Key Regional Insights

Asia-Pacific is one of the most dynamic regions for preventive healthcare technologies, supported by large populations, rising chronic disease prevalence, and government-backed digital health initiatives in China, India, Japan, South Korea, Singapore, and Australia. Aging demographics in Japan and South Korea strengthen demand for fall prevention, remote monitoring, dementia risk management, and early detection services, while India and Southeast Asian economies are scaling digital identity, primary care access, vaccination records, and community-based screening.

North America leads in commercial digital health adoption, employer wellness, genomics, reimbursement-linked preventive care, and regulated digital medicine, with the United States providing scale and Canada emphasizing primary care access, public health equity, and population-level screening. Latin America is expanding prevention through public and private primary care networks, mobile-first access, diabetes and obesity management, and vaccination initiatives, with Brazil and Mexico playing central roles in chronic disease prevention. Europe benefits from national screening programs, strong data protection rules, interoperable health data strategies, and coordinated public health policies, particularly across cancer screening, immunization, cardiovascular risk management, and healthy aging.

The Middle East is investing in preventive care as part of healthcare transformation agendas, particularly in GCC states that are targeting obesity, diabetes, cardiovascular disease, and longevity through digital health platforms, national health records, and lifestyle medicine. Africa is leveraging mobile health, community health workers, vaccination programs, maternal and child health initiatives, and infectious disease surveillance to extend preventive services, although broadband access, workforce shortages, diagnostic infrastructure, and financing constraints continue to shape adoption.

Key Group Insights

ASEAN markets are advancing preventive healthcare through digital health platforms, primary care modernization, universal coverage expansion, and cross-border collaboration on infectious disease surveillance. Singapore's technology-enabled care model often acts as a regional benchmark, while Indonesia, Thailand, Vietnam, Malaysia, and the Philippines are expanding access through mobile health, immunization programs, community screening, and digital public health tools.

The GCC is prioritizing prevention to address obesity, diabetes, cardiovascular risk, cancer screening, and healthy aging, supported by national health transformation programs, connected care infrastructure, and growing investment in population health analytics. The European Union is emphasizing interoperability, cancer screening, vaccination, secure data sharing, and health technology regulation through policies such as the European Health Data Space and medical device rules. BRICS countries provide scale for population health innovation across China, India, Brazil, Russia, and South Africa, but adoption varies by infrastructure, reimbursement maturity, workforce capacity, and digital inclusion.

G7 markets lead in clinical standards, AI governance, advanced diagnostics, genomics, reimbursement design, and investment capacity, making them important reference points for evidence-based preventive healthcare technologies. NATO members increasingly view preventive health, biosecurity, pandemic preparedness, vaccination readiness, workforce resilience, and secure health data infrastructure as strategic priorities that connect public health with national security planning.

Key Country Insights

The United States remains a leading environment for preventive healthcare technologies due to payer innovation, employer-sponsored wellness, strong digital health adoption, regulated software pathways, and extensive use of preventive service recommendations in coverage policy. Canada emphasizes equitable prevention through public healthcare systems, vaccination, cancer screening, and primary care renewal, while Mexico and Brazil are using public and private primary care networks to address diabetes, obesity, hypertension, cardiovascular disease, and maternal and child health priorities.

In Europe, the United Kingdom, Germany, France, Italy, and Spain support preventive care through national health systems, cancer screening, vaccination programs, electronic health records, digital health reimbursement reforms, and chronic disease management initiatives. Germany's digital health reimbursement pathways, the United Kingdom's population health analytics, France's prevention planning, and Italy's and Spain's regional care models strengthen adoption, while Russia continues to focus on public health monitoring, infectious disease control, and chronic disease prevention.

China is scaling prevention through Healthy China 2030, hospital digitalization, public health surveillance, chronic disease management, and consumer health platforms. India's Ayushman Bharat Digital Mission, Health and Wellness Centres, and primary care expansion support screening access at scale for hypertension, diabetes, cancer, maternal health, and immunization. Japan, Australia, and South Korea are strong adopters of aging-related prevention, connected devices, remote monitoring, health checkup programs, and digital care coordination, reflecting their emphasis on longevity, early diagnosis, and health system efficiency.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated solutions that demonstrate measurable reductions in risk, cost, missed screenings, disease progression, or care gaps. Products must integrate with electronic health records, payer workflows, pharmacy systems, laboratory networks, connected devices, and public health registries to move from standalone wellness tools to embedded preventive care infrastructure.

Investment should focus on evidence generation, privacy-by-design architecture, cybersecurity, inclusive datasets, accessibility, and reimbursement alignment. Organizations that partner with providers, employers, governments, and insurers can scale faster by tying preventive healthcare technologies to recognized quality measures, screening guidelines, vaccination targets, chronic disease management objectives, and health equity goals.

Research Methodology

This executive summary is developed using a secondary and analytical research approach that draws on publicly available and regularly cited sources, including the World Health Organization, OECD, World Bank, national health agencies, regulatory bodies, payer policy documents, digital health regulations, and peer-reviewed public health literature.

The methodology emphasizes triangulation across epidemiological burden, demographic trends, reimbursement structures, digital health regulation, preventive care guidelines, interoperability initiatives, and technology adoption indicators. Insights are interpreted through market relevance, clinical validity, regional policy maturity, health equity implications, data governance, and scalability of preventive healthcare technologies and services.

Conclusion

Preventive healthcare technologies and services are becoming essential to the future of sustainable health systems. The strongest opportunities are emerging where clinical evidence, connected data, AI-enabled risk prediction, secure interoperability, and accessible service delivery converge.

Organizations that can prove outcomes, protect patient trust, and integrate prevention into routine care will be best positioned to lead. As chronic disease burden, aging populations, infectious disease preparedness needs, and healthcare cost pressures intensify, prevention is shifting from a public health aspiration to a strategic operating model for healthcare systems worldwide.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Preventive Healthcare Technologies & Services Market, by Service

  • 7.1. Genetic Testing Services
    • 7.1.1. Carrier Screening
    • 7.1.2. Hereditary Cancer Testing
    • 7.1.3. Pharmacogenomic Testing
  • 7.2. Lifestyle Management
    • 7.2.1. Fitness Coaching
    • 7.2.2. Nutritional Counseling
    • 7.2.3. Stress Management
  • 7.3. Predictive Analytics
    • 7.3.1. AI-Based Predictive Models
    • 7.3.2. Risk Assessment Tools
  • 7.4. Preventive Screening
    • 7.4.1. Cancer Screening
    • 7.4.2. Cardiovascular Screening
    • 7.4.3. Diabetes Screening
    • 7.4.4. Osteoporosis Screening
  • 7.5. Vaccination Services
    • 7.5.1. Seasonal Vaccination
    • 7.5.2. Travel Vaccination
    • 7.5.3. Workplace Vaccination

8. Preventive Healthcare Technologies & Services Market, by Delivery Mode

  • 8.1. Home-Based
    • 8.1.1. Home Visits
    • 8.1.2. Self-Administered
  • 8.2. In-Person
    • 8.2.1. Clinic-Based
    • 8.2.2. Hospital-Based
    • 8.2.3. Pharmacy-Based
  • 8.3. Mobile Clinics
    • 8.3.1. Bus Clinics
    • 8.3.2. Pop-Up Clinics
  • 8.4. Virtual
    • 8.4.1. App-Based
    • 8.4.2. Remote Monitoring
    • 8.4.3. Teleconsultation

9. Preventive Healthcare Technologies & Services Market, by Technology Type

  • 9.1. Early Detection And Screening Technologies
  • 9.2. Chronic Disease Management Technologies
  • 9.3. Vaccination Technologies
  • 9.4. Digital Health Solutions
  • 9.5. Wearable Technologies

10. Preventive Healthcare Technologies & Services Market, by End User

  • 10.1. Ambulatory Care Centers
    • 10.1.1. Clinics
    • 10.1.2. Diagnostic Centers
  • 10.2. Corporate Wellness Providers
    • 10.2.1. On-Site Programs
    • 10.2.2. Virtual Programs
  • 10.3. Home Care Settings
    • 10.3.1. Remote Monitoring At Home
    • 10.3.2. Self-Administered
  • 10.4. Hospitals
    • 10.4.1. Primary Hospitals
    • 10.4.2. Specialty Hospitals
  • 10.5. Individuals
    • 10.5.1. Direct-To-Consumer Products
    • 10.5.2. Self-Service Apps

11. Preventive Healthcare Technologies & Services Market, by Application

  • 11.1. Cardiovascular Disease Prevention
    • 11.1.1. Cholesterol Monitoring
    • 11.1.2. Hypertension Management
    • 11.1.3. Lifestyle Intervention
  • 11.2. Diabetes Prevention
    • 11.2.1. Blood Glucose Monitoring
    • 11.2.2. Lifestyle Coaching
  • 11.3. Infectious Disease Prevention
    • 11.3.1. Immunization
    • 11.3.2. Prophylactic Treatments
  • 11.4. Oncology Screening
    • 11.4.1. Breast Cancer Screening
    • 11.4.2. Colorectal Cancer Screening
    • 11.4.3. Lung Cancer Screening

12. Preventive Healthcare Technologies & Services Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Preventive Healthcare Technologies & Services Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Preventive Healthcare Technologies & Services Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Abbott Laboratories
  • 16.2. Accenture PLC
  • 16.3. AliveCor Inc
  • 16.4. Alphabet Inc
  • 16.5. Apple Inc
  • 16.6. CitiusTech Inc
  • 16.7. Cognizant Technology Solutions Corporation
  • 16.8. Dexcom Inc
  • 16.9. Garmin Ltd
  • 16.10. General Electric HealthCare Technologies Inc
  • 16.11. GSK plc
  • 16.12. Illumina Inc
  • 16.13. Johnson & Johnson
  • 16.14. Koninklijke Philips N.V.
  • 16.15. McKesson Corporation
  • 16.16. Medtronic plc
  • 16.17. Merck & Co Inc
  • 16.18. Moderna Inc
  • 16.19. Myriad Genetics Inc
  • 16.20. Pfizer Inc
  • 16.21. Quest Diagnostics Incorporated
  • 16.22. ResMed Inc
  • 16.23. Roche Holding AG
  • 16.24. Siemens Healthineers AG
  • 16.25. Tata Consultancy Services Limited
  • 16.26. Teladoc Health Inc
  • 16.27. UnitedHealth Group Incorporated
  • 16.28. Wipro Limited

LIST OF FIGURES

  • FIGURE 1. GLOBAL PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY SERVICE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY SERVICE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY DELIVERY MODE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY DELIVERY MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL GENETIC TESTING SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL GENETIC TESTING SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL GENETIC TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CARRIER SCREENING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CARRIER SCREENING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CARRIER SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL HEREDITARY CANCER TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL HEREDITARY CANCER TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL HEREDITARY CANCER TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PHARMACOGENOMIC TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PHARMACOGENOMIC TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PHARMACOGENOMIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL LIFESTYLE MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL LIFESTYLE MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL LIFESTYLE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL FITNESS COACHING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL FITNESS COACHING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL FITNESS COACHING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL NUTRITIONAL COUNSELING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL NUTRITIONAL COUNSELING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL NUTRITIONAL COUNSELING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL STRESS MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL STRESS MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL STRESS MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PREDICTIVE ANALYTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PREDICTIVE ANALYTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PREDICTIVE ANALYTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL AI-BASED PREDICTIVE MODELS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL AI-BASED PREDICTIVE MODELS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL AI-BASED PREDICTIVE MODELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL RISK ASSESSMENT TOOLS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL RISK ASSESSMENT TOOLS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL RISK ASSESSMENT TOOLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PREVENTIVE SCREENING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PREVENTIVE SCREENING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PREVENTIVE SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CANCER SCREENING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CANCER SCREENING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CANCER SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CARDIOVASCULAR SCREENING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CARDIOVASCULAR SCREENING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CARDIOVASCULAR SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL DIABETES SCREENING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL DIABETES SCREENING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL DIABETES SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL OSTEOPOROSIS SCREENING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL OSTEOPOROSIS SCREENING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL OSTEOPOROSIS SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL VACCINATION SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL VACCINATION SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL VACCINATION SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SEASONAL VACCINATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SEASONAL VACCINATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SEASONAL VACCINATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL TRAVEL VACCINATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL TRAVEL VACCINATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL TRAVEL VACCINATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL WORKPLACE VACCINATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL WORKPLACE VACCINATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL WORKPLACE VACCINATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL HOME-BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL HOME-BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL HOME-BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL HOME VISITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL HOME VISITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL HOME VISITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL SELF-ADMINISTERED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL SELF-ADMINISTERED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL SELF-ADMINISTERED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL IN-PERSON MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL IN-PERSON MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL IN-PERSON MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL CLINIC-BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL CLINIC-BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL CLINIC-BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL HOSPITAL-BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL HOSPITAL-BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL HOSPITAL-BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PHARMACY-BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PHARMACY-BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PHARMACY-BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL MOBILE CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL MOBILE CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL MOBILE CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL BUS CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL BUS CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL BUS CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL POP-UP CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL POP-UP CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL POP-UP CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL VIRTUAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL VIRTUAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL VIRTUAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL APP-BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL APP-BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL APP-BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL REMOTE MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL REMOTE MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL REMOTE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL TELECONSULTATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL TELECONSULTATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL TELECONSULTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL EARLY DETECTION AND SCREENING TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL EARLY DETECTION AND SCREENING TECHNOLOGIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL EARLY DETECTION AND SCREENING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL CHRONIC DISEASE MANAGEMENT TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL CHRONIC DISEASE MANAGEMENT TECHNOLOGIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL CHRONIC DISEASE MANAGEMENT TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL VACCINATION TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL VACCINATION TECHNOLOGIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL VACCINATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL DIGITAL HEALTH SOLUTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL DIGITAL HEALTH SOLUTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL DIGITAL HEALTH SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL WEARABLE TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL WEARABLE TECHNOLOGIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL WEARABLE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL CORPORATE WELLNESS PROVIDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL CORPORATE WELLNESS PROVIDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL CORPORATE WELLNESS PROVIDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL ON-SITE PROGRAMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL ON-SITE PROGRAMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL ON-SITE PROGRAMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL VIRTUAL PROGRAMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL VIRTUAL PROGRAMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL VIRTUAL PROGRAMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL REMOTE MONITORING AT HOME MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL REMOTE MONITORING AT HOME MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL REMOTE MONITORING AT HOME MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL SELF-ADMINISTERED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL SELF-ADMINISTERED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL SELF-ADMINISTERED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL PRIMARY HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL PRIMARY HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL PRIMARY HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL SPECIALTY HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL SPECIALTY HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL SPECIALTY HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL INDIVIDUALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL INDIVIDUALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL INDIVIDUALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL DIRECT-TO-CONSUMER PRODUCTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL DIRECT-TO-CONSUMER PRODUCTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL DIRECT-TO-CONSUMER PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL SELF-SERVICE APPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL SELF-SERVICE APPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL SELF-SERVICE APPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL CARDIOVASCULAR DISEASE PREVENTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL CARDIOVASCULAR DISEASE PREVENTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL CARDIOVASCULAR DISEASE PREVENTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL CHOLESTEROL MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL CHOLESTEROL MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL CHOLESTEROL MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL HYPERTENSION MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL HYPERTENSION MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL HYPERTENSION MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. GLOBAL LIFESTYLE INTERVENTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL LIFESTYLE INTERVENTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL LIFESTYLE INTERVENTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. GLOBAL DIABETES PREVENTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 182. GLOBAL DIABETES PREVENTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL DIABETES PREVENTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 185. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. GLOBAL LIFESTYLE COACHING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 188. GLOBAL LIFESTYLE COACHING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 189. GLOBAL LIFESTYLE COACHING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. GLOBAL INFECTIOUS DISEASE PREVENTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 191. GLOBAL INFECTIOUS DISEASE PREVENTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 192. GLOBAL INFECTIOUS DISEASE PREVENTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. GLOBAL IMMUNIZATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 194. GLOBAL IMMUNIZATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 195. GLOBAL IMMUNIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. GLOBAL PROPHYLACTIC TREATMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 197. GLOBAL PROPHYLACTIC TREATMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 198. GLOBAL PROPHYLACTIC TREATMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. GLOBAL ONCOLOGY SCREENING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 200. GLOBAL ONCOLOGY SCREENING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 201. GLOBAL ONCOLOGY SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 203. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 204. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. GLOBAL COLORECTAL CANCER SCREENING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 206. GLOBAL COLORECTAL CANCER SCREENING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 207. GLOBAL COLORECTAL CANCER SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. GLOBAL LUNG CANCER SCREENING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 209. GLOBAL LUNG CANCER SCREENING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 210. GLOBAL LUNG CANCER SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. GLOBAL PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 212. ASIA-PACIFIC PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 213. ASIA-PACIFIC PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 214. ASIA-PACIFIC PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY GENETIC TESTING SERVICES, 2018-2032 (USD MILLION)
  • TABLE 215. ASIA-PACIFIC PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY LIFESTYLE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 216. ASIA-PACIFIC PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2032 (USD MILLION)
  • TABLE 217. ASIA-PACIFIC PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY PREVENTIVE SCREENING, 2018-2032 (USD MILLION)
  • TABLE 218. ASIA-PACIFIC PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY VACCINATION SERVICES, 2018-2032 (USD MILLION)
  • TABLE 219. ASIA-PACIFIC PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 220. ASIA-PACIFIC PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY HOME-BASED, 2018-2032 (USD MILLION)
  • TABLE 221. ASIA-PACIFIC PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY IN-PERSON, 2018-2032 (USD MILLION)
  • TABLE 222. ASIA-PACIFIC PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY MOBILE CLINICS, 2018-2032 (USD MILLION)
  • TABLE 223. ASIA-PACIFIC PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY VIRTUAL, 2018-2032 (USD MILLION)
  • TABLE 224. ASIA-PACIFIC PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. ASIA-PACIFIC PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 226. ASIA-PACIFIC PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 227. ASIA-PACIFIC PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY CORPORATE WELLNESS PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 228. ASIA-PACIFIC PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 229. ASIA-PACIFIC PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 230. ASIA-PACIFIC PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY INDIVIDUALS, 2018-2032 (USD MILLION)
  • TABLE 231. ASIA-PACIFIC PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY CARDIOVASCULAR DISEASE PREVENTION, 2018-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY DIABETES PREVENTION, 2018-2032 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY INFECTIOUS DISEASE PREVENTION, 2018-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY ONCOLOGY SCREENING, 2018-2032 (USD MILLION)
  • TABLE 236. NORTH AMERICA PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 238. NORTH AMERICA PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY GENETIC TESTING SERVICES, 2018-2032 (USD MILLION)
  • TABLE 239. NORTH AMERICA PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY LIFESTYLE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 240. NORTH AMERICA PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2032 (USD MILLION)
  • TABLE 241. NORTH AMERICA PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY PREVENTIVE SCREENING, 2018-2032 (USD MILLION)
  • TABLE 242. NORTH AMERICA PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY VACCINATION SERVICES, 2018-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 244. NORTH AMERICA PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY HOME-BASED, 2018-2032 (USD MILLION)
  • TABLE 245. NORTH AMERICA PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY IN-PERSON, 2018-2032 (USD MILLION)
  • TABLE 246. NORTH AMERICA PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY MOBILE CLINICS, 2018-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY VIRTUAL, 2018-2032 (USD MILLION)
  • TABLE 248. NORTH AMERICA PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 250. NORTH AMERICA PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 251. NORTH AMERICA PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY CORPORATE WELLNESS PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 252. NORTH AMERICA PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 253. NORTH AMERICA PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 254. NORTH AMERICA PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY INDIVIDUALS, 2018-2032 (USD MILLION)
  • TABLE 255. NORTH AMERICA PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 256. NORTH AMERICA PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY CARDIOVASCULAR DISEASE PREVENTION, 2018-2032 (USD MILLION)
  • TABLE 257. NORTH AMERICA PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY DIABETES PREVENTION, 2018-2032 (USD MILLION)
  • TABLE 258. NORTH AMERICA PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY INFECTIOUS DISEASE PREVENTION, 2018-2032 (USD MILLION)
  • TABLE 259. NORTH AMERICA PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY ONCOLOGY SCREENING, 2018-2032 (USD MILLION)
  • TABLE 260. LATIN AMERICA PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 261. LATIN AMERICA PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 262. LATIN AMERICA PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY GENETIC TESTING SERVICES, 2018-2032 (USD MILLION)
  • TABLE 263. LATIN AMERICA PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY LIFESTYLE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 264. LATIN AMERICA PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2032 (USD MILLION)
  • TABLE 265. LATIN AMERICA PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY PREVENTIVE SCREENING, 2018-2032 (USD MILLION)
  • TABLE 266. LATIN AMERICA PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY VACCINATION SERVICES, 2018-2032 (USD MILLION)
  • TABLE 267. LATIN AMERICA PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 268. LATIN AMERICA PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY HOME-BASED, 2018-2032 (USD MILLION)
  • TABLE 269. LATIN AMERICA PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY IN-PERSON, 2018-2032 (USD MILLION)
  • TABLE 270. LATIN AMERICA PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY MOBILE CLINICS, 2018-2032 (USD MILLION)
  • TABLE 271. LATIN AMERICA PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY VIRTUAL, 2018-2032 (USD MILLION)
  • TABLE 272. LATIN AMERICA PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 273. LATIN AMERICA PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 274. LATIN AMERICA PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 275. LATIN AMERICA PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY CORPORATE WELLNESS PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 276. LATIN AMERICA PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 277. LATIN AMERICA PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 278. LATIN AMERICA PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY INDIVIDUALS, 2018-2032 (USD MILLION)
  • TABLE 279. LATIN AMERICA PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 280. LATIN AMERICA PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY CARDIOVASCULAR DISEASE PREVENTION, 2018-2032 (USD MILLION)
  • TABLE 281. LATIN AMERICA PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY DIABETES PREVENTION, 2018-2032 (USD MILLION)
  • TABLE 282. LATIN AMERICA PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY INFECTIOUS DISEASE PREVENTION, 2018-2032 (USD MILLION)
  • TABLE 283. LATIN AMERICA PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY ONCOLOGY SCREENING, 2018-2032 (USD MILLION)
  • TABLE 284. EUROPE PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 285. EUROPE PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 286. EUROPE PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY GENETIC TESTING SERVICES, 2018-2032 (USD MILLION)
  • TABLE 287. EUROPE PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY LIFESTYLE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 288. EUROPE PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2032 (USD MILLION)
  • TABLE 289. EUROPE PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY PREVENTIVE SCREENING, 2018-2032 (USD MILLION)
  • TABLE 290. EUROPE PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY VACCINATION SERVICES, 2018-2032 (USD MILLION)
  • TABLE 291. EUROPE PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 292. EUROPE PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY HOME-BASED, 2018-2032 (USD MILLION)
  • TABLE 293. EUROPE PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY IN-PERSON, 2018-2032 (USD MILLION)
  • TABLE 294. EUROPE PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY MOBILE CLINICS, 2018-2032 (USD MILLION)
  • TABLE 295. EUROPE PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY VIRTUAL, 2018-2032 (USD MILLION)
  • TABLE 296. EUROPE PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 297. EUROPE PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 298. EUROPE PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 299. EUROPE PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY CORPORATE WELLNESS PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 300. EUROPE PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 301. EUROPE PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 302. EUROPE PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY INDIVIDUALS, 2018-2032 (USD MILLION)
  • TABLE 303. EUROPE PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 304. EUROPE PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY CARDIOVASCULAR DISEASE PREVENTION, 2018-2032 (USD MILLION)
  • TABLE 305. EUROPE PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY DIABETES PREVENTION, 2018-2032 (USD MILLION)
  • TABLE 306. EUROPE PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY INFECTIOUS DISEASE PREVENTION, 2018-2032 (USD MILLION)
  • TABLE 307. EUROPE PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY ONCOLOGY SCREENING, 2018-2032 (USD MILLION)
  • TABLE 308. MIDDLE EAST PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 309. MIDDLE EAST PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY SERVICE, 2018-2032 (USD MILLION)
  • TABLE 310. MIDDLE EAST PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY GENETIC TESTING SERVICES, 2018-2032 (USD MILLION)
  • TABLE 311. MIDDLE EAST PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY LIFESTYLE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 312. MIDDLE EAST PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2032 (USD MILLION)
  • TABLE 313. MIDDLE EAST PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY PREVENTIVE SCREENING, 2018-2032 (USD MILLION)
  • TABLE 314. MIDDLE EAST PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY VACCINATION SERVICES, 2018-2032 (USD MILLION)
  • TABLE 315. MIDDLE EAST PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 316. MIDDLE EAST PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY HOME-BASED, 2018-2032 (USD MILLION)
  • TABLE 317. MIDDLE EAST PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY IN-PERSON, 2018-2032 (USD MILLION)
  • TABLE 318. MIDDLE EAST PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY MOBILE CLINICS, 2018-2032 (USD MILLION)
  • TABLE 319. MIDDLE EAST PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY VIRTUAL, 2018-2032 (USD MILLION)
  • TABLE 320. MIDDLE EAST PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 321. MIDDLE EAST PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 322. MIDDLE EAST PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 323. MIDDLE EAST PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY CORPORATE WELLNESS PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 324. MIDDLE EAST PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 325. MIDDLE EAST PREVENTIVE HEALTHCARE TECHNOLOGIES & SERVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 326. MIDDLE E